These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7725926)

  • 41. Intragastric and intraduodenal investigations.
    Malagelada JR
    Scand J Gastroenterol Suppl; 1982; 75():44-7. PubMed ID: 6959250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Rennie Liquid versus Maalox Liquid on intragastric pH in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers.
    Hürlimann S; Michel K; Inauen W; Halter F
    Am J Gastroenterol; 1996 Jun; 91(6):1173-80. PubMed ID: 8651166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the in vitro interactions of cimetidine with commercial antacid preparations and chemically pure components.
    Allgayer H; Paumgartner G
    Arzneimittelforschung; 1984; 34(8):870-1. PubMed ID: 6541923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability and buffer capacity of antacids. A randomized double-blind study for the comparison of the most used antacid solutions].
    Becker HD; Degenhardt T
    Fortschr Med; 1981 Sep; 99(33):1318-20. PubMed ID: 7028583
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparative in vitro research on 2 new antacid combinations--Ulsan and Ulsan D].
    Chakŭrski I; Dobrev Kh; Dobreva P
    Vutr Boles; 1987; 26(5):86-90. PubMed ID: 3433734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between sparfloxacin and antacids - dissolution and adsorption studies.
    Hussain F; Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Jan; 19(1):16-21. PubMed ID: 16632447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro determination of the neutralizing capacity of antacids].
    Brunner H
    Z Gastroenterol; 1983 Mar; 21 Suppl():22-5. PubMed ID: 6858407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of antacid compounds containing both aluminum and magnesium. II. Codried powders.
    Peterson CL; Perry DL; Masood H; White JL; Hem SL; Fritsch C; Haeusler F
    Pharm Res; 1993 Jul; 10(7):1005-7. PubMed ID: 8378241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
    Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
    Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Formulation of aspirin-magaldrate double-layer tablets: in vitro evaluation and cytoprotective activity in rats.
    al Gohary OM; el Din K; el Tahir H
    Boll Chim Farm; 1996; 135(7):421-8. PubMed ID: 9035555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of composition on the neutralizing properties of antacid preparations.
    Pawlaczyk J; Lutka A; Kokot Z
    Pharmazie; 1984 May; 39(5):334-6. PubMed ID: 6473495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of in vitro and in vivo methodology for evaluation of antacids.
    Smyth RD; Herczeg T; Wheatley TA; Hause W; Reavey-Cantwell NH
    J Pharm Sci; 1976 Jul; 65(7):1045-7. PubMed ID: 8626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of formulation on antacid value of magnesium trisilicate tablets.
    Jovanovic M; Samardzic Z; Djuric Z; Zajic L
    Acta Pharm Hung; 1988 Sep; 58(5):215-20. PubMed ID: 2853555
    [No Abstract]   [Full Text] [Related]  

  • 54. [In vitro studies of antacids. I].
    Schnekenburger J
    Arzneimittelforschung; 1974 Feb; 24(2):142-4. PubMed ID: 4406362
    [No Abstract]   [Full Text] [Related]  

  • 55. [A comparative evaluation of the antacid properties of the preparations Maalox and Almagel].
    Grebenev AL; Sheptulin AA; Okhlobystin AV
    Ter Arkh; 1994; 66(8):44-7. PubMed ID: 7985154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dissolution study of the gentin tablets].
    Tsagareishvili NT; Bakuridze AD; Kurdiani NG; Murtazashvili TZh
    Georgian Med News; 2006 Apr; (133):94-6. PubMed ID: 16705241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of As-Di-Sol primojel and polyplasdone XL as adjuvants in antacid tablets.
    Jovanović M; Samardzić Z; Djurić Z; Zivanović L
    Pharmazie; 1988 Oct; 43(10):727. PubMed ID: 3212024
    [No Abstract]   [Full Text] [Related]  

  • 58. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)].
    Baur C; Becker A; Linder R; Schwan T
    Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
    Propst A; Propst T; Judmaier G
    Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A layered lattice antacid with long-term effectiveness. Profile of action and safety exemplified by magaldrate].
    Kurtz W
    Fortschr Med; 1993 Feb; 111(6):93-6. PubMed ID: 8462913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.